Eric Thompson, MD

Brain Tumor Specialist, Pediatric Neurosurgeon

Eric Thompson

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Siteman Kids at St. Louis Children’s Hospital

Siteman Kids at St. Louis Children’s Hospital

On WashU Medicine Campus
1 Children's Place, St. Louis, MO 63110

Expertise & Training

Video thumbnail for Eric M Thompson, MD

Watch video on YouTube

Eric M Thompson, MD

5 mins

Eric M. Thompson, MD, Pediatric Neurosurgeon from Siteman Cancer Center discusses the diagnosis and treatment of pediatric brain tumors, including the latest surgical approaches and personalized care for children with brain and spinal tumors.

Clinical Expertise

  • Pediatric Neurosurgery

Primary Academic Title

Professor of Neurosurgery, Pediatric Neurosurgery, T.S. Park, MD, Chair in Pediatric Neurosurgery, Chief, Division of Pediatric Neurosurgery, WashU Medicine

Board Certification

  • 2017: American Board of Neurological Surgery
  • 2018: American Board of Pediatric Neurological Surgery

Training

  • 2006 - 2013: Neurological Surgery Residency, Oregon Health & Sciences University, Portland, OR
  • 2008 - 2011: Neuro-Oncology Research Fellowship, Oregon Health & Sciences University, Portland, OR
  • 2013 - 2014: Fellowship in Pediatric Neurosurgery, Hospital for Sick Children, Toronto, ON

Education

  • 2002: BS, Duke University, Durham, NC
  • 2006: MD, University of Nebraska College of Medicine, Omaha, NE

Research & Selected Publications

Research Interest

The Thompson Lab investigates the molecular mechanisms of and treatment for leptomeningeal dissemination of pediatric brain tumors, focusing on the Abelson family of nonreceptor tyrosine kinases (ABL1 and ABL 2). The lab also develops immunotherapies to treat malignant pediatric brain tumors, focusing on peptide vaccines that target CMV antigens. Dr. Eric Thompson is also the Principal Investigator of multiple investigator initiated clinical trials of immunotherapy to treat malignant pediatric brain tumors.

Research Publications

Peptide Vaccines for Pediatric High-Grade Glioma and Diffuse Midline Glioma: Current Progress and Future Perspectives
Authors:

Mebrahtu AK, Jain V, Moelker EM, one or more additional authors omitted Thompson EM

Journal & Year:

Vaccines (Basel) | 2025

A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial
Authors:

Thompson EM, Ashley DM, Ayasoufi K, one or more additional authors omitted Landi D

Journal & Year:

Nat Cancer | 2025

Enhanced plasma and brain concentrations and medulloblastoma cytotoxicity of asciminib and nilotinib by P-glycoprotein inhibition with tariquidar
Authors:

Thompson EM, Cheng L, Spasojevic I

Journal & Year:

Anticancer Drugs | 2025

Medulloblastoma chapter - past perspectives and future directions
Authors:

Govender D, de Monaco BA, Dhall G, Thompson EM

Journal & Year:

Adv Cancer Res | 2025